Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

A statement of beneficial ownership of common stock by certain persons

SC 13G
3,4,5
0000919574-18-005712.pdf 0000919574-18-005712.rtf 0000919574-18-005712.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Greenleaf Peter 0000899243-18-022577.pdf 0000899243-18-022577.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Watson W. Mark 0000899243-18-022575.pdf 0000899243-18-022575.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capita 0000899243-18-022576.pdf 0000899243-18-022576.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Davis Todd C 0000899243-18-022574.pdf 0000899243-18-022574.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0000899243-18-022309.pdf 0000899243-18-022309.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-244338.pdf 0001193125-18-244338.rtf 0001193125-18-244338.xls View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
0001193125-18-244507.pdf 0001193125-18-244507.rtf 0001193125-18-244507.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
0000921895-18-002225.pdf 0000921895-18-002225.rtf 0000921895-18-002225.xls View HTML

An amendment to a 3 filing. Non-EDGAR filing

3/A
3,4,5
Broadfin Capita 0000899243-18-021566.pdf 0000899243-18-021566.rtf View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon